Treatment of infections associated with surgical implants.
By R. Darouiche. New England Journal of Medicine, 2004
2,174 citations recorded by the source corpus.
Subfields: Epidemiology, Surgery
View Paper: https://www.semanticscholar.org/paper/50da3c716168b35dc920a02459157e61a3818281
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Surgery
Citations in the corpus
- Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention (2018, background): “In the early 2000s, nosocomial infections (hospital-acquired infections that appear within 2e30 days of hospital stay) accounted for 2 million cases of infections and 90,000 deaths in the US alone [17, 104].”
- Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. (2013, neutral): “nous or oral antimicrobial therapy [1–4].”
- Review of titanium surface modification techniques and coatings for antibacterial applications. (2019, background): “Besides, cephalothin, carbenicillin, amoxicillin, cefamandol, tobramycin, and vancomycin have also been used in coatings on bone implants.[7] On the other hand, the drug incorporation strategy into coatings as well as drug release rates from coatings are two important aspects, for they can highly in”
- A review on the wettability of dental implant surfaces II: Biological and clinical aspects. (2014, background): “Biomaterial-associated infections represent a small percentage but result in serious complications in the orthopaedic field [99, 100].”
- The Future of Biologic Coatings for Orthopaedic Implants (2013, background): “costly to the patient and society in general [8].”
- Antibacterial nano-structured titania coating incorporated with silver nanoparticles. (2011, neutral): “Titanium (Ti) implants are widely used clinically, but implant associated infection remains one of the most serious complications and is usually difficult to treat sometimes requiring implant removal and repeated surgeries [1,2].”
- Contemporary clinical profile and outcome of prosthetic valve endocarditis. (2007, methodology): ““Non-nosocomial health care–associated infection” was defined as IE diagnosed within 48 hours of admission in an outpatient with extensive health care contact as reflected by any of the following criteria: (1) received intravenous therapy, wound care, or specialized nursing care at home within the 3”